Investor Profile
International business leader with over 35 years of experience in telecommunications, digital services and telemedicine — from Orange and Nortel to multiple ventures across France, Germany, the UK, Italy and the USA.
In 2017, he sold ACETIAM, a global telemedicine operator of 80 staff. After co-founding imagerie.fr and VIZYON (AI teleradiology) and selling imagerie.fr in July 2023, Eric now dedicates his time to investing in and supporting healthcare innovators.
Investment portfolio
Innovative design of custom orthotics using 3D scanning and printing — treating plantar pain, bunions and gait disorders with personalised care.
Visit →Collaborative telehealth platform enabling patients to receive care at home, integrating vitals, appointments and records.
Visit →Early-stage investment fund supporting exceptional founders in medtech, digital health and AI diagnostics.
Visit →Streamlines medical photo management and remote wound monitoring via smartphone — saving up to 1.5 hours of clinical time per day.
Visit →Uses AI to analyse patients' immune systems and personalise surgical care — reducing post-operative complications.
Visit →Cardiac telerehabilitation enabling patients to follow their programme at home with remote multidisciplinary support.
Visit →Democratises diagnostics with a programmable molecular testing platform — one-pot tests targeting any DNA/RNA pathogen.
Visit →Holistic medical centres combining gynaecological consultations, paramedical care and wellness for women at every stage of life.
Visit →Uses AI to adapt texts for dyslexic children — turning homework into a game in collaboration with clinicians and teachers.
Visit →Develops skin organoid models from iPSC — precision in vitro testing for pharma and cosmetics without animal models.
Visit →Created Dryum, the first mechanically powered negative pressure wound therapy device — single-use and ultra-portable.
Visit →